Anebulo Pharmaceuticals, Inc. Contracts & Agreements
26 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (3)
- Human Resources (9)
- Intellectual Property (1)
- Real Estate (1)
- Uncategorized (3)
- Loan and Security Agreement dated November 13, 2023, among the Company, 22NW LP as administrative agent, collateral agent and as a lender, and JFL Capital Management LLC (Filed With SEC on November 14, 2023)
- Executive Employment Agreement, dated October 5, 2023, between the Company and Richard Anthony Cunningham (Filed With SEC on October 6, 2023)
- Offer Letter, effective September 26, 2023, between the Company and Daniel George (Filed With SEC on September 29, 2023)
- Master Services Agreement, dated March 2, 2023, between the Company and Potrero Hill Advisors, LLC (Filed With SEC on March 8, 2023)
- Form of Common Stock Purchase Warrant, issued September 28, 2022 (Filed With SEC on September 29, 2022)
- Securities Purchase Agreement, dated September 25, 2022, by and between the Company and the purchasers named therein (Filed With SEC on September 29, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on September 9, 2022)
- Sublease Agreement, dated August 15, 2020, as amended on August 1, 2022, between Anebulo Pharmaceuticals, Inc. and JFL Capital Management LLC (Filed With SEC on September 9, 2022)
- Employment Agreement, dated January 1, 2021, between Rex Merchant and Anebulo Pharmaceuticals, Inc (Filed With SEC on September 9, 2022)
- Anebulo Pharmaceuticals, Inc. 2020 Stock Incentive Plan, as amended, and Form of Award Agreement thereunder (Filed With SEC on September 9, 2022)
- Description of Securities (Filed With SEC on September 9, 2022)
- Employment Agreement, effective as of May 20, 2022, between Anebulo Pharmaceuticals, Inc. and Kenneth Cundy (Filed With SEC on May 24, 2022)
- Employment Agreement, effective as of February 1, 2022, between Anebulo Pharmaceuticals, Inc. and Simon Allen (Filed With SEC on January 5, 2022)
- Form of Underwriting Agreement (Filed With SEC on April 26, 2021)
- Specimen Stock Certificate for Common Stock (Filed With SEC on April 1, 2021)
- Consultancy Agreement, dated July 15, 2020, between Anebulo Pharmaceuticals, Inc. and Traxeus Pharma Services Limited (Filed With SEC on April 1, 2021)
- Form of Indemnification Agreement between Anebulo Pharmaceuticals, Inc. and each of its directors (Filed With SEC on April 1, 2021)
- Anebulo Pharmaceuticals, Inc. 2020 Stock Incentive Plan, and Form of Award Agreement thereunder (Filed With SEC on April 1, 2021)
- Amendment No. 1 to Employment Agreement, dated January 22, 2021, between Daniel Schneeberger and Anebulo Pharmaceuticals, Inc (Filed With SEC on April 1, 2021)
- Employment Agreement, dated July 21, 2020, between Daniel Schneeberger and Anebulo Pharmaceuticals, Inc (Filed With SEC on April 1, 2021)
- License Agreement, dated May 26, 2020, between Vernalis (R&D) Limited and Anebulo Pharmaceuticals, Inc (Filed With SEC on April 1, 2021)
- Investors Rights Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
- Right of First Refusal and Co-Sale Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
- Series A Preferred Stock Purchase Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
- Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Filed With SEC on April 1, 2021)
- Warrant to Purchase Shares of Preferred Stock, dated as of March 8, 2021, between Anebulo Pharmaceuticals, Inc. and Aron English (Filed With SEC on April 1, 2021)
